China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
China Resources Boya Bio pharmaceutical Group Co Ltd
Pre-Tax Income
China Resources Boya Bio pharmaceutical Group Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
|
Pre-Tax Income
¥324.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
12%
|
|
Beigene Ltd
HKEX:6160
|
Pre-Tax Income
-¥6.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Pre-Tax Income
-¥1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Pre-Tax Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Pre-Tax Income
¥8.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
35%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Pre-Tax Income
¥1.5B
|
CAGR 3-Years
62%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
See Also
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Pre-Tax Income?
Pre-Tax Income
324.2m
CNY
Based on the financial report for Mar 31, 2024, China Resources Boya Bio pharmaceutical Group Co Ltd's Pre-Tax Income amounts to 324.2m CNY.
What is China Resources Boya Bio pharmaceutical Group Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
12%
Over the last year, the Pre-Tax Income growth was -47%. The average annual Pre-Tax Income growth rates for China Resources Boya Bio pharmaceutical Group Co Ltd have been -1% over the past three years , -11% over the past five years , and 12% over the past ten years .